Logo image of CNVS

CINEVERSE CORP (CNVS) Stock Fundamental Analysis

NASDAQ:CNVS - Nasdaq - US1724063086 - Common Stock - Currency: USD

2.93  +0.06 (+2.09%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CNVS. CNVS was compared to 72 industry peers in the Entertainment industry. CNVS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CNVS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CNVS has reported negative net income.
CNVS had a positive operating cash flow in the past year.
In the past 5 years CNVS reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: CNVS reported negative operating cash flow in multiple years.
CNVS Yearly Net Income VS EBIT VS OCF VS FCFCNVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

CNVS has a Return On Assets of -15.30%. This is in the lower half of the industry: CNVS underperforms 69.44% of its industry peers.
CNVS has a Return On Equity of -32.93%. This is comparable to the rest of the industry: CNVS outperforms 45.83% of its industry peers.
CNVS's Return On Invested Capital of 11.32% is amongst the best of the industry. CNVS outperforms 88.89% of its industry peers.
Industry RankSector Rank
ROA -15.3%
ROE -32.93%
ROIC 11.32%
ROA(3y)-14.52%
ROA(5y)-28.21%
ROE(3y)-28.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNVS Yearly ROA, ROE, ROICCNVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

With a decent Operating Margin value of 8.04%, CNVS is doing good in the industry, outperforming 76.39% of the companies in the same industry.
CNVS has a Gross Margin of 53.40%. This is in the better half of the industry: CNVS outperforms 61.11% of its industry peers.
In the last couple of years the Gross Margin of CNVS has declined.
Industry RankSector Rank
OM 8.04%
PM (TTM) N/A
GM 53.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.81%
GM growth 5Y-2.67%
CNVS Yearly Profit, Operating, Gross MarginsCNVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

5

2. Health

2.1 Basic Checks

CNVS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CNVS has been increased compared to 1 year ago.
Compared to 5 years ago, CNVS has more shares outstanding
The debt/assets ratio for CNVS is higher compared to a year ago.
CNVS Yearly Shares OutstandingCNVS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CNVS Yearly Total Debt VS Total AssetsCNVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

CNVS has an Altman-Z score of -6.83. This is a bad value and indicates that CNVS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.83, CNVS is doing worse than 83.33% of the companies in the same industry.
CNVS has a debt to FCF ratio of 1.79. This is a very positive value and a sign of high solvency as it would only need 1.79 years to pay back of all of its debts.
The Debt to FCF ratio of CNVS (1.79) is better than 83.33% of its industry peers.
CNVS has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
CNVS's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. CNVS outperforms 68.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.79
Altman-Z -6.83
ROIC/WACC1.32
WACC8.58%
CNVS Yearly LT Debt VS Equity VS FCFCNVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

CNVS has a Current Ratio of 1.15. This is a normal value and indicates that CNVS is financially healthy and should not expect problems in meeting its short term obligations.
CNVS's Current ratio of 1.15 is fine compared to the rest of the industry. CNVS outperforms 61.11% of its industry peers.
CNVS has a Quick Ratio of 1.15. This is a normal value and indicates that CNVS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.15, CNVS is doing good in the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
CNVS Yearly Current Assets VS Current LiabilitesCNVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

CNVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.98%, which is quite impressive.
The Revenue has grown by 39.86% in the past year. This is a very strong growth!
CNVS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.69% yearly.
EPS 1Y (TTM)98.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
Revenue 1Y (TTM)39.86%
Revenue growth 3Y16.09%
Revenue growth 5Y-1.69%
Sales Q2Q%206.87%

3.2 Future

CNVS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.64% yearly.
CNVS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.97% yearly.
EPS Next Y103.7%
EPS Next 2Y36.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year53%
Revenue Next 2Y21.97%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNVS Yearly Revenue VS EstimatesCNVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CNVS Yearly EPS VS EstimatesCNVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2019 2021 2022 2023 2024 2025 2026 0 -20 -40 -60 -80 -100

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNVS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CNVS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNVS Price Earnings VS Forward Price EarningsCNVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNVS indicates a rather cheap valuation: CNVS is cheaper than 86.11% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNVS indicates a somewhat cheap valuation: CNVS is cheaper than 75.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.81
EV/EBITDA 4.25
CNVS Per share dataCNVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as CNVS's earnings are expected to grow with 36.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.64%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CNVS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CINEVERSE CORP

NASDAQ:CNVS (5/2/2025, 8:00:01 PM)

2.93

+0.06 (+2.09%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)06-30 2025-06-30/amc
Inst Owners15.47%
Inst Owner Change0.45%
Ins Owners12.7%
Ins Owner Change5.07%
Market Cap46.82M
Analysts82.5
Price Target8.67 (195.9%)
Short Float %1.61%
Short Ratio1.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.88%
Min EPS beat(2)9.29%
Max EPS beat(2)26.47%
EPS beat(4)3
Avg EPS beat(4)14.23%
Min EPS beat(4)-50.83%
Max EPS beat(4)71.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.01%
Min Revenue beat(2)9.79%
Max Revenue beat(2)16.23%
Revenue beat(4)2
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-15.94%
Max Revenue beat(4)16.23%
Revenue beat(8)2
Avg Revenue beat(8)-3.31%
Revenue beat(12)6
Avg Revenue beat(12)7.35%
Revenue beat(16)9
Avg Revenue beat(16)7.26%
PT rev (1m)0%
PT rev (3m)13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-200%
EPS NY rev (1m)0%
EPS NY rev (3m)-50%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.65
P/FCF 21.81
P/OCF 12.73
P/B 1.25
P/tB 3.66
EV/EBITDA 4.25
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.13
FCFY4.59%
OCF(TTM)0.23
OCFY7.86%
SpS4.53
BVpS2.34
TBVpS0.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.3%
ROE -32.93%
ROCE 15.83%
ROIC 11.32%
ROICexc 13.31%
ROICexgc 46.31%
OM 8.04%
PM (TTM) N/A
GM 53.4%
FCFM 2.96%
ROA(3y)-14.52%
ROA(5y)-28.21%
ROE(3y)-28.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.81%
GM growth 5Y-2.67%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.79
Debt/EBITDA 0.4
Cap/Depr 40.67%
Cap/Sales 2.11%
Interest Coverage 5.42
Cash Conversion 38.35%
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z -6.83
F-Score6
WACC8.58%
ROIC/WACC1.32
Cap/Depr(3y)25.17%
Cap/Depr(5y)25.31%
Cap/Sales(3y)1.73%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
EPS Next Y103.7%
EPS Next 2Y36.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)39.86%
Revenue growth 3Y16.09%
Revenue growth 5Y-1.69%
Sales Q2Q%206.87%
Revenue Next Year53%
Revenue Next 2Y21.97%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y234.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year381.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y125.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y147.35%
OCF growth 3YN/A
OCF growth 5YN/A